Logotype for Sumitomo Chemical Company Limited

Sumitomo Chemical Company (4005) Q2 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Sumitomo Chemical Company Limited

Q2 2025 earnings summary

1 Jul, 2026

Executive summary

  • Core operating income for H1 FY2024 achieved a V-shaped recovery, up over ¥120 billion year-on-year, led by IT-related Chemicals and Pharmaceuticals; net loss of ¥6.5 billion was recorded, mainly due to foreign exchange losses and Petro Rabigh debt forgiveness.

  • Full-year FY2024 forecast: core operating income of ¥100 billion and net income of ¥25 billion, both revised upward despite one-off losses.

  • Accelerated business portfolio upgrades, with a raised cash generation target of ¥700 billion and expected reduction of interest-bearing liabilities by ¥300 billion.

  • Structural reforms underway, including cost reductions and sales expansion in Pharma, operational optimization in domestic petrochemicals, and a new 4-segment organization launched in October 2024.

  • Interim dividend of ¥3 per share declared, with annual DPS maintained at ¥9.

Financial highlights

  • H1 FY2024 sales revenue: ¥1,241.4 billion, up ¥54.5 billion year-on-year; core operating income: ¥29.5 billion; net loss: ¥6.5 billion.

  • Core operating income increased by ¥126.1 billion year-on-year, marking a significant recovery.

  • All segments improved year-on-year; IT-related Chemicals income rose ¥19.7 billion to a record high of ¥37.5 billion.

  • Health & Crop Sciences saw profit growth due to methionine market recovery, increased crop protection shipments, and yen depreciation.

  • Full-year forecast: sales revenue ¥2,600 billion, core operating income ¥100 billion, net income ¥25 billion (including a ¥46 billion one-off loss).

Outlook and guidance

  • FY2024 core operating income forecast remains at ¥100 billion, with segment-level ups and downs; net income forecast at ¥25 billion.

  • Essential Chemicals expected to decrease by ¥24 billion due to Petro Rabigh's downturn; IT-related Chemicals forecast to increase by ¥10 billion.

  • FY2025 target: maintain core operating income at ¥100 billion, focusing on organic growth and improved Rabigh performance.

  • New medium-term management plan to be formulated under a reorganized structure starting October.

  • Dividend policy maintained at ¥9 per share for FY2024, with a future aim of ¥24/share or more.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more